Search Results

He then earned his Ph.D. in physical chemistry from the Massachusetts Institute of Technology, training training in the laboratories of Professors Raymond Stevens and Kurt Wüthrich at The Scripps Research Institute

Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center.

Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center.

Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center.

training as a postdoctoral fellow at the Vanderbilt Center for Neuroscience Drug Discovery, the National Institute of General Medical Sciences, and the National Institute on Alcohol Abuse and Alcoholism.

How an integrated training and lab structure at Monash Institute of Pharmaceutical Sciences fosters innovation Associate Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology at Monash Institute More about Michelle Halls Monash Institute of Pharmaceutical Sciences Bluesky LinkedIn Articles about

of the most prestigious Clinician Postdoctoral Fellowships offered by Alberta Innovates and Canadian Institutes Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined of using protein-targeted degradation as a therapeutic strategy. " Victoria Rasmussen on the web Tri-Institutional

After returning to Germany I set up my own lab at the Institute of Physiology at Würzburg, where I later Leipzig University, where I now head the Department of General Biochemistry at the Rudolf Schönheimer Institute

of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry Perkins Institute on the web LinkedIn ResearchGate Pubmed Google Scholar University of Western Australia Harry Perkins Institute

networking, mentorship, PhD resilience, COVID-19 challenges, and his aspiration to transition into biotechnology

included research at the École Polytechnique Fédérale de Lausanne (2015–2016) and later at the Max Planck Institute Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Johannes Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular

Johannes Broichhagen Group Leader Leibniz Research Institute for Molecular Pharmacology (FMP), Berlin doctorate at LMU Munich in 2014, and undertook postdoctoral work at EPFL (Switzerland) and the Max Planck Institute He previously served as Professor of Cellular Metabolism and Institute Deputy Director at the University

Davide Calebiro is Chair of Molecular Endocrinology and Wellcome Trust Senior Research Fellow at the Institute Between 2009 and 2017, he was a Group Leader at the Institute of Pharmacology and Toxicology and Rudolf

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies

Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985, In 2018, he moved to Harrington Discovery Institute and Case Western Reserve University, where he studies

Being a biochemist by training, she completed her Ph.D. at the Institute of Biochemistry at the University Liebscher is a Professor at the Rudolf Schönheimer Institute of Biochemistry at the Medical Faculty of

Scientific Themes of the Conversation Lab continuity during institutional shutdown — What it takes to scientific failure — The gap between what infectious disease researchers had been warning about and what institutions The failure wasn't epistemic — it was institutional. Terry Hébert on the web Terry Hébert | Institute of Health Sciences Education Hébert Lab LinkedIn Hébert

Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig Claudia Stäubert on the web Stäubert Lab, Rudolf Schönheimer Institute of Biochemistry Leipzig LinkedIn GPCR, discussed with Claudia, a guest from the Schiller Institute at Campstream, about Claudia's work

Germany and a Ph.D. in molecular pharmacology (supervisor: Bertil B Fredholm; 1998-2002) from Karolinska Institutet As a postdoc, he trained first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology; 2003

in vitro Pharmacology at 7TM Pharma in Denmark; Full professor, department chair and director of the institute

University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes From 1987 to 1994, they were the Director of Biocomputing at The Salk Institute, where they managed institute-wide

While a chemistry undergraduate student at the University of Chicago, he attended a NATO Advanced Study Institute After moving to Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced

He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging

Masha earned her Bachelor’s degree in chemistry, followed by a direct Ph.D. at the Institute of Chemistry

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology

dopamine receptors at the University of Kent and postdoctoral training on Class B GPCRs at the National Institute

Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic

Elva Zhao About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical